Autori: Wanner Christoph
| Naslov | Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes (Review) |
| Autori | Davies Melanie J Drexel Heinz Jornayvaz Francois R Pataky Zoltan Seferovic Petar M Wanner Christoph |
| Info | CARDIOVASCULAR DIABETOLOGY, (2022), vol. 21 br. 1, str. - |
| Projekat | Fortis Pharma Communications; Boehringer Ingelheim |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Long-Term Evaluation of Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with Hyperphosphataemia (Article) |
| Autori | Locatelli Francesco Spasovski Goce B Dimkovic Nada B Wanner Christoph |
| Info | BLOOD PURIFICATION, (2016), vol. 41 br. 4, str. 247-253 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with Hyperphosphatemia (Article) |
| Autori | Hertel Joachim Locatelli Francesco Spasovski Goce B Dimkovic Nada B Wanner Christoph |
| Info | NEPHRON, (2015), vol. 130 br. 4, str. 229-238 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study (Article) |
| Autori | Locatelli Francesco Spasovski Goce B Dimkovic Nada B Wanner Christoph Dellanna Frank Pontoriero Giuseppe |
| Info | NEPHROLOGY DIALYSIS TRANSPLANTATION, (2014), vol. 29 br. 5, str. 1061-1073 |
| Projekat | Mitsubishi Pharma Europe Ltd. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
